---
title: "Rotapharm Limited — Ownership Dossier"
canonical: https://whiteintel.dev/entity/39bf64c6-9041-5d77-983d-3cbba1b32256
json: https://whiteintel.dev/api/public/dossier/39bf64c6-9041-5d77-983d-3cbba1b32256
identifier: icij:icijol-215713
jurisdiction: BY
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Rotapharm Limited

**Type:** Company  
**Jurisdiction:** BY  
**Identifier:** `icij:icijol-215713`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/39bf64c6-9041-5d77-983d-3cbba1b32256  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/39bf64c6-9041-5d77-983d-3cbba1b32256  

## Ownership & control

### Owners / controllers

- **Kate Miles** (director of) — https://whiteintel.dev/entity/1453f65e-b16f-56f6-ab6d-9006b50adf12

### UBO chain (walk to the ultimate owner)

1. **Kate Miles** — director of → *Rotapharm Limited*

## Provenance

- ICIJ Offshore Leaks — https://offshoreleaks.icij.org/nodes/215713

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Rotapharm Limited**. Human view: https://whiteintel.dev/entity/39bf64c6-9041-5d77-983d-3cbba1b32256 · Structured JSON: https://whiteintel.dev/api/public/dossier/39bf64c6-9041-5d77-983d-3cbba1b32256._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._